INTEGRATION OF CAPSULAR POLYSACCHARIDE BIOSYNTHESIS WITH METABOLIC AND VIRULENCE PATHWAYS IN STREPTOCOCCUS PNEUMONIAE

4th Edition: Virulence Mechanisms of Bacterial Pathogens

Volumn , Issue , 2022, Pages 51-66

  Yother, Janet ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85151196604     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815851.ch4     Document Type: Chapter

References (78)

1. Abeyta, M., G. G. Hardy, and J. Yother. 2003. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect. Immun. 71:218-225.
2. Advisory Committee on Immunization Practices. 1997. Prevention of pneumococcal disease. Morb. Mortal. Wkly. Rep. 46:1-24.
3. Arrecubieta, C., E. Garcia, and R. Lopez. 1995. Sequence and transcriptional analysis of a DNA region involved in the production of capsular polysaccharide in Streptococcus pneumoniae type 3. Gene 167:1-7.
4. Austrian, R. 1981. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev. Infect. Dis. 3(Suppl):S1-S17.
5. Avery, O. T., and R. Dubos. 1931. The protective action of a specific enzyme against type III pneumococcus infection in mice. J. Exp. Med. 54:73-89.
6. Bender, M. H., R. T. Cartee, and J. Yother. 2003. Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae. J. Bacteriol. 185:6057-6066.
7. Bender, M. H., and J. Yother. 2001. CpsB is a modulator of capsule-associated tyrosine kinase activity in Streptococcus pneumoniae. J. Biol. Chem. 276:47966-47974.
8. Bentley, S. D., D. M. Aanensen, A. Mavroidi, D. Saunders, E. Rabbinowitsch, M. Collins, K. Donohoe, D. Harris, L. Murphy, M. A. Quail, G. Samuel, I. C. Skovsted, M. S. Kaltoft, B. Barrell, P. R. Reeves, J. Parkhill, and B. G. Spratt. 2006. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2:e31.
9. Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60:111-116.
10. Briles, D. E., J. Horowitz, L. S. McDaniel, W. H. Benjamin, Jr., J. L. Claflin, C. L. Booker, G. Scott, and C. Forman. 1986. Genetic control of susceptibility to pneumococcal infection. Curr. Top. Microbiol. Immunol. 124:103-120.
11. Briles, D. E., M. Nahm, K. Schoroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153:694-705.
12. Brown, E. J., S. W. Hosea, C. H. Hammer, C. G. Burch, and M. M. Frank. 1982. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J. Clin. Investig. 69:85-98.
13. Brown, E. J., K. A. Joiner, R. M. Cole, and M. Berger. 1983. Localization of complement component 3 on Streptococcus pneumoniae: anticapsular antibody causes complement deposition on the pneumococcal capsule. Infect. Immun. 39:403-409.
14. Bukantz, S. C., P. F. de Gara, and J. G. M. Bullowa. 1942. Capsular polysaccharide in the blood of patients with pneumococcic pneumonia. Arch. Intern. Med. 69:191-212.
15. Caimano, M. J., G. G. Hardy, and J. Yother. 1998. Capsule genetics in Streptococcus pneumoniae and a possible role for transposition in the generation of the type 3 locus. Microbial Drug Resist. 4:11-23.
16. Campbell, J. A., G. J. Davies, V. Bulone, and B. Henrissat. 1997. A classification of nucleotidediphospho-sugar glycosyltransferases based on amino acid sequence similarities. Biochem. J. 326:929-942.
17. Cartee, R. T., W. T. Forsee, M. H. Bender, K. D. Ambrose, and J. Yother. 2005. CpsE from type 2 Streptococcus pneumoniae catalyzes the reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, initiating type 2 capsule repeat unit synthesis. J. Bacteriol. 187:7425-7433.
18. Cartee, R. T., W. T. Forsee, J. W. Jensen, and J. Yother. 2001. Expression of the Streptococcus pneumoniae type 3 synthase in Escherichia coli: assembly of type 3 polysaccharide on a lipid primer. J. Biol. Chem. 276:48831-48839.
19. Cartee, R. T., W. T. Forsee, J. S. Schutzbach, and J. Yother. 2000. Mechanism of type 3 capsular polysaccharide synthesis in Streptococcus pneumoniae. J. Biol. Chem. 275:3907-3914.
20. Cartee, R. T., W. T. Forsee, and J. Yother. 2005. Initiation and synthesis of the Streptococcus pneumoniae type 3 capsule on a phosphatidylglycerol membrane anchor. J. Bacteriol. 187:4470-4479.
21. Chaffin, D. O., L. M. Mentele, and C. E. Rubens. 2005. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J. Bacteriol. 187:4615-4626.
22. Darkes, M. J., and G. L. Plosker. 2002. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Paediatr. Drugs 4:609-630.
23. Deng, L., D. L. Kasper, T. P. Krick, and M. R. Wessels. 2000. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group. B Streptococcus. J. Biol. Chem. 275:7497-7504.
24. Dillard, J. P., M. W. Vandersea, and J. Yother. 1995. Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae. J. Exp. Med. 181:973-983.
25. Dillard, J. P., and J. Yother. 1994. Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3. Mol. Microbiol. 12:959-972.
26. Fine, D. P. 1975. Pneumococcal type-associated variability in alternate complement pathway activation. Infect. Immun. 12:772-778.
27. Finland, M., and M. Barnes. 1977. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J. Clin. Microbiol. 5:154-166.
28. Fischer, W., T. Behr, R. Hartmann, J. Peter-Katalinic, and H. Egge. 1993. Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae have identical chain structures. A reinvestigation of teichoic acid (C-polysaccharide). Eur. J. Biochem. 215:851-857.
29. Forsee, W. T., R. T. Cartee, and J. Yother. 2000. Biosynthesis of type 3 capsular polysaccharide in Streptococcus pneumoniae: enzymatic chain release by an abortive translocation process. J. Biol. Chem. 275:25972-25978.
30. Forsee, W. T., R. T. Cartee, and J. Yother. 2006. Role of the carbohydrate binding site of the Streptococcus pneumoniae capsular polysaccharide type 3 synthase in the transition from oligosaccharide to polysaccharide synthesis. J. Biol. Chem. 281:6283-6289.
31. Giammarinaro, P., and J. C. Paton. 2002. Role of RegM, a homologue of the catabolite repressor protein CcpA, in the virulence of Streptococcus pneumoniae. Infect. Immun. 70:5454-5461.
32. Grangeasse, C., P. Doublet, E. Vaganay, C. Vincent, G. Deleage, B. Duclos, and A. J. Cozzone. 1997. Characterization of a bacterial gene encoding an autophosphorylating protein tyrosine kinase. Gene 204:259-265.
33. Gray, B. G., and J. H. C. Dillon. 1986. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr. Infect. Dis. 5:201-207.
34. Griffith, F. 1928. The significance of pneumococcal types. J. Hyg. 27:113-159.
35. Guidolin, A., J. K. Morona, R. Morona, D. Hansman, and J. C. Paton. 1994. Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F. Infect. Immun. 62:5384-5396.
36. Hardy, G. G., M. J. Caimano, and J. Yother. 2000. Capsule biosynthesis and basic metabolism in Streptococcus pneumoniae are linked through the cellular phosphoglucomutase. J. Bacteriol. 182:1854-1863.
37. Hardy, G. G., A. D. Magee, C. L. Ventura, M. J. Caimano, and J. Yother. 2001. Essential role for cellular phosphoglucomutase in virulence of type 3 Streptococcus pneumoniae. Infect. Immun. 69:2309-2317.
38. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:2759-2762.
39. Hostetter, M. K. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J. Infect. Dis. 153:682-693.
40. Iannelli, F., B. J. Pearce, and G. Pozzi. 1999. The type 2 capsule locus of Streptococcus pneumoniae. J. Bacteriol. 181:2652-2654.
41. Ilan, O., Y. Bloch, G. Frankel, H. Ullrich, K. Geider, and I. Rosenshine. 1999. Protein tyrosine phosphorylation kinases in bacterial pathogens are associated with virulence and production of exopolysaccharide. EMBO J. 18:3241-3248.
42. Jansson, P. E., B. Lindberg, M. Anderson, U. Lindquist, and J. Henrichsen. 1988. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation. Carbohydr. Res. 182:111-117.
43. Keenleyside, W. J., and C. Whitfield. 1996. A novel pathway of O-polysaccharide biosynthesis in Salmonella enterica serovar Borreze. J. Biol. Chem. 271:28581-28592.
44. Kelly, T., J. P. Dillard, and J. Yother. 1994. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect. Immun. 62:1813-1819.
45. Kim, J. O., and J. N. Weiser. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177:368-377.
46. Lazarevic, V., P. Margot, B. Soldo, and D. Karamata. 1992. Sequencing and analysis of the Bacillus subtilis lytRABC divergon: a regulatory unit encompassing the structural genes of the Nacetylmuramoyl-l-alanine amidase and its modifier. J. Gen. Microbiol. 138:1949-1961.
47. Lesinski, G. B., and M. A. Westerink. 2001. Vaccines against polysaccharide antigens. Curr. Drug Targets Infect. Disord. 1:325-334.
48. Llull, D., E. García, and R. López. 2001. Tts, a processive beta-glucosyltransferase of Streptococcus pneumoniae, directs the synthesis of the branched type 37 capsular polysaccharide in pneumococcus and other gram-positive species. J. Biol. Chem. 276:21053-21061.
49. Llull, D., R. Munoz, R. Lopez, and E. Garcia. 1999. A single gene (tts) located outside the cap locus directs the formation of Streptococcus pneumoniae type 37 capsular polysaccharide. Type 37 pneumococci are natural, genetically binary strains. J. Exp. Med. 190:241-251.
50. MacLeod, C. M., R. G. Hodges, M. Heildeberger, and W. G. Bernhard. 1945. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J. Exp. Med. 82:445-465.
51. MacLeod, C. M., and M. R. Krauss. 1950. Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro. J. Exp. Med. 92:1-9.
52. Magee, A. D., and J. Yother. 2001. Requirement for capsule in colonization by. Streptococcus pneumoniae. Infect. Immun. 69:3755-3761.
53. Mollerach, M., R. Lopez, and E. Garcia. 1998. Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis. J. Exp. Med. 188:2047-2056.
54. 4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. J. Bacteriol. 185:3009-3019.
55. Morona, J. K., R. Morona, D. C. Miller, and J. C. Paton. 2002. Streptococcus pneumoniae capsule biosynthesis protein CpsB is a novel manganesedependent phosphotyrosine-protein phosphatase. J. Bacteriol. 184:577-583.
56. Morona, J. K., R. Morona, and J. C. Paton. 1997. Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathway. Mol. Microbiol. 23:751-763.
57. Morona, J. K., J. C. Paton, D. C. Miller, and R. Morona. 2000. Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol. Microbiol. 35:1431-1442.
58. Mosser, J. L., and A. Tomasz. 1970. Cholinecontaining teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J. Biol. Chem. 245:287-298.
59. O’Brien, K. L., and M. Santosham. 2004. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am. J. Epidemiol. 159:634-644.
60. Park, I. H., D. G. Pritchard, R. Cartee, A. Brandao, M. C. C. Brandileone, and M. H. Nahm. 2007. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol. 45:1225-1233.
61. Ramos, A., I. C. Boels, W. M. de Vos, and H. Santos. 2001. Relationship between glycolysis and exopolysaccharide biosynthesis in Lactococcus lactis. Appl. Environ. Microbiol. 67:33-41.
62. Sorensen, U. B., J. Henrichsen, H. C. Chen, and S. C. Szu. 1990. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb. Pathog. 8:325-334.
63. Thomas, J. D., P. Sideras, C. I. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Co-localization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355-358.
64. Titgemeyer, F., and W. Hillen. 2002. Global control of sugar metabolism: a gram-positive solution. Antonie Leeuwenhoek 82:59-71.
65. van Dam, J. E., A. Fleer, and H. Snippe. 1990. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Leeuwenhoek 58:1-47.
66. Ventura, C. L., R. T. Cartee, W. T. Forsee, and J. Yother. 2006. Control of capsular polysaccharide chain length by UDP-sugar substrate concentrations in Streptococcus pneumoniae. Mol. Microbiol. 61:723-733.
67. Vincent, C., P. Doublet, C. Grangeasse, E. Vaganay, A. J. Cozzone, and B. Duclos. 1999. Cells of Escherichia coli contain a protein-tyrosine kinase, Wzc, and a phosphotyrosine-protein phosphatase, Wzb. J. Bacteriol. 181:3472-3477.
68. Vollmer, W., and A. Tomasz. 2000. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 275:20496-20501.
69. Weigel, P. H., V. C. Hascall, and M. Tammi. 1997. Hyaluronan synthases. J. Biol. Chem. 272:13997-14000.
70. Weiser, J. N., R. Austrian, P. K. Sreenivasan, and H. R. Masure. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
71. Weiser, J. N., D. Bae, H. Epino, S. B. Gordon, M. Kapoor, L. A. Zenewicz, and M. Shchepetov. 2001. Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae. Infect. Immun. 69:5430-5439.
72. Whitfield, C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75:39-68.
73. Wicker, L. S., and I. Scher. 1986. X-linked immune deficiency (xid) of CBA/N mice. Curr. Top. Microbiol. Immunol. 124:87-101.
74. Winkelstein, J. A., A. S. Abramovitz, and A. Tomasz. 1980. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J. Immunol. 124:2502-2506.
75. Wugeditsch, T., A. Paiment, J. Hocking, J. Drummelsmith, C. Forrester, and C. Whitfield. 2001. Phosphorylation of Wzc, a tyrosine autokinase, is essential for assembly of group 1 capsular polysaccharides in Escherichia coli. J. Biol. Chem. 276:2361-2371.
76. Xayarath, B., and J. Yother. 2007. Mutations blocking side chain assembly, polymerization, or transport of a Wzy-dependent Streptococcus pneumoniae capsule are lethal in the absence of suppressor mutations and can affect polymer transfer to the. cell wall. J. Bacteriol. 189:3369-3381.
77. Yother, J., K. D. Ambrose, and M. J. Caimano. 1997. Association of a partial H-rpt element with the type 3 capsule locus of Streptococcus pneumoniae. Mol. Microbiol. 25:201-204.
78. Yother, J., and J. M. White. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176:2976-2985.